Literature DB >> 7054232

Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease.

S I Rennard, R G Crystal.   

Abstract

Fibronectin is a major adhesive and opsonic glycoprotein found in plasma and tissues. Because this molecule appears to mediate a number of interactions between cells and extracellular matrix, and because the interstitial lung disease are characterized by marked derangements of the pulmonary extracellular matrix, we evaluated fibronectin in the lower respiratory tract in patients with these disorders. Fibronectin could be detected in the bronchoalveolar lavage fluid of normals (11/11), as well as those with noninterstitial lung diseases (18/18), idiopathic pulmonary fibrosis (21/21), sarcoidosis (20/20), and other interstitial lung diseases (22/22). Compared with normal and those with noninterstitial lung disease, the levels in bronchoalveolar lavage of patients with interstitial disease were significantly higher (P less than 0.01), all comparisons). This was true only for bronchoalveolar lavage fibronectin; plasma levels were similar in all study groups (P greater than 0.2, all comparisons). The lavage fluid fibronectin was intact antigenically and retained collagen binding capability, although in some cases of interstitial disease, the presence of lower molecular weight fragments suggested some degradation. Thus, fibronectin is a normal constituent of the epithelial fluid of the lower respiratory tract and is present in increased amounts in a significant number of individuals with interstitial lung disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054232      PMCID: PMC371174          DOI: 10.1172/jci110421

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Transalveolar transport of large polar solutes (sucrose, inulin, and dextran).

Authors:  J Theodore; E D Robin; R Gaudio; J Acevedo
Journal:  Am J Physiol       Date:  1975-10

2.  Localization of the cell attachment region in types I and II collagens.

Authors:  H K Kleinman; E B McGoodwin
Journal:  Biochem Biophys Res Commun       Date:  1976-09-20       Impact factor: 3.575

3.  Restoration of normal morphology, adhesion and cytoskeleton in transformed cells by addition of a transformation-sensitive surface protein.

Authors:  I U Ali; V Mautner; R Lanza; R O Hynes
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

4.  Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage.

Authors:  H Y Reynolds; H H Newball
Journal:  J Lab Clin Med       Date:  1974-10

5.  Isolation of a collagen-dependent cell attachment factor.

Authors:  R J Klebe
Journal:  Nature       Date:  1974-07-19       Impact factor: 49.962

6.  Plasma protein pattern in recurrent cholestasis of pregnancy.

Authors:  B Forkman; P O Ganrot; G Gennser; G Rannevik
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Authors:  H Y Reynolds; J D Fulmer; J A Kazmierowski; W C Roberts; M M Frank; R G Crystal
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

9.  Identification of the cold-insoluble globulin of plasma in amniotic fluid.

Authors:  A B Chen; M W Mosesson; G I Solish
Journal:  Am J Obstet Gynecol       Date:  1976-08-01       Impact factor: 8.661

Review 10.  Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects.

Authors:  R G Crystal; J D Fulmer; W C Roberts; M L Moss; B R Line; H Y Reynolds
Journal:  Ann Intern Med       Date:  1976-12       Impact factor: 25.391

View more
  24 in total

1.  Effect of acrylonitrile on the procoagulant activity of rat lung.

Authors:  T Bhooma; B Padmavathi; S N Devaraj
Journal:  Bull Environ Contam Toxicol       Date:  1992-02       Impact factor: 2.151

2.  Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells.

Authors:  S T Pottratz; W J Martin
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  Fibronectin production by cultured human lung fibroblasts in three-dimensional collagen gel culture.

Authors:  Y Adachi; T Mio; K Takigawa; I Striz; D J Romberger; J R Spurzem; S I Rennard
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-03       Impact factor: 2.416

Review 4.  Characteristics and clinical significance of the lymphocytic alveolitis in interstitial lung disorders.

Authors:  G A Rossi; B Balbi; S Lantero; C Ravazzoni
Journal:  Lung       Date:  1990       Impact factor: 2.584

5.  Evaluation of fibronectin gene expression by in situ hybridization. Differential expression of the fibronectin gene among populations of human alveolar macrophages.

Authors:  K Adachi; K Yamauchi; J F Bernaudin; P Fouret; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

6.  Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.

Authors:  P B Bitterman; M D Wewers; S I Rennard; S Adelberg; R G Crystal
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

7.  Modulation of fibronectin gene expression in human mononuclear phagocytes.

Authors:  K Yamauchi; Y Martinet; R G Crystal
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

8.  PAS staining of bronchoalveolar lavage cells for differential diagnosis of interstitial lung disease.

Authors:  Hans P Hauber; Peter Zabel
Journal:  Diagn Pathol       Date:  2009-04-23       Impact factor: 2.644

9.  Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.

Authors:  J Chastre; P Brun; J B Fourtillan; P Soler; G Basset; C Manuel; J L Trouillet; C Gibert
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

10.  Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis.

Authors:  Thanh-Thuy T Le; Harry Karmouty-Quintana; Ernestina Melicoff; Thanh-Truc T Le; Tingting Weng; Ning-Yuan Chen; Mesias Pedroza; Yang Zhou; Jonathan Davies; Kemly Philip; Jose Molina; Fayong Luo; Anuh T George; Luis J Garcia-Morales; Raquel R Bunge; Brian A Bruckner; Matthias Loebe; Harish Seethamraju; Sandeep K Agarwal; Michael R Blackburn
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.